Try a new search

Format these results:

Searched for:

in-biosketch:true

person:husais06

Total Results:

172


Claims-Based Phenotyping of Acute Kidney Transplant Rejection in a National Medicare Cohort

Ekanayake, Cameron; Yu, Miko; Natarajan, Karthik; Husain, Syed A; Muppavarapu, Chetan Sree; Schold, Jesse; Mohan, Sumit
INTRODUCTION/UNASSIGNED:National transplant registries record acute rejection (AR) without the granularity needed to study rejection heterogeneity and prognosis at scale. Whether AR can be stratified by type and severity in national claims data using a claims-based algorithm, and whether these phenotypes correlate with graft outcomes, remains unclear. METHODS/UNASSIGNED:We conducted a cohort study using the US Renal Data System (USRDS) data including adult kidney transplant recipients from 2012-2021. AR within 12 months posttransplant was identified using International Classification of Diseases codes for transplant complications with evidence of antirejection treatment within 2 weeks. Episodes were categorized by type and severity based on treatment regimen. Biopsy-associated AR was defined by renal biopsy within 14 days before the treatment. Death-censored graft survival was assessed using Kaplan-Meier methods and multivariable Cox proportional hazards models. RESULTS/UNASSIGNED:< 0.05]), with trends persisting after adjustment for recipient and donor characteristics. CONCLUSION/UNASSIGNED:Claims-based phenotyping can identify clinically meaningful AR subtypes and prognostic gradients at national scale, enabling more granular national rejection surveillance.
PMCID:13677584
PMID: 42898365
ISSN: 2468-0249
CID: 6074865

Precision, Pragmatism, and Emerging Paradigms in Determining Kidney Filtration Function

Potluri, Vishnu S; Husain, Syed A; Reese, Peter P
PMID: 42240151
ISSN: 1538-3598
CID: 6044352

Newly Designed Expedited Allocation Pathways Cannot Be Expected to Rely on Data That Does Not Currently Exist

Ekanayake, Cameron D; Husain, Syed A; Yu, Miko E; Adler, Joel T; Muppavarapu, Chetan Sree; Schold, Jesse D; Mohan, Sumit
PMID: 41893905
ISSN: 2641-7650
CID: 6018772

Variation of eGFR Wait Time Modifications for Black Kidney Transplant Candidates in the United States

Schold, Jesse D; Arrigain, Susana; Husain, S Ali; Yu, Miko; Lopez, Rocio; Brosi, Deena; LaVanchy, Ryan; Mohan, Sumit
PMID: 40327843
ISSN: 1533-3450
CID: 5868152

Financial Toxicity in ESKD

Maclay, Lindsey M; Woodward, Kyle; Strohmayer, Natalie; Yu, Miko E; Mohan, Sumit; Huml, Anne M; Husain, Syed Ali
BACKGROUND:Patients with kidney failure require treatments that are demanding and time-intensive, potentially interfering with employability and leading to indirect costs. We sought to characterize the prevalence of, and risk factors for financial toxicity among patients with kidney failure. METHODS:We conducted a cross-sectional survey study of 112 participants with kidney failure at a large, urban, academic medical center. Financial toxicity was assessed via a survey which included the validated CoST tool as well as additional items to evaluate self-reported changes to material conditions and financial coping behaviors. Participants were grouped according to kidney replacement therapy modality (dialysis, transplant after dialysis, or preemptive transplant) Descriptive statistics were used to summarize demographic and clinical characteristics of the study population and to compare those with above-median vs below-medial CoST scores, and by modality of kidney replacement therapy. RESULTS:Median CoST score was 17 with 71% of participants experiencing at least mild financial toxicity. Participants experiencing financial toxicity were less likely to have White race, and more likely to be receiving dialysis. Over half of participants reported reduction in employment (61%) or income (57%) following kidney failure onset with the greatest likelihood of these among participants with any dialysis. CONCLUSIONS:Adults with kidney failure experience significant financial toxicity as measured by the CoST score and report significant negative changes in employment and income. Although this toxicity persists through many stages of treatment, treatment modality may impact financial burdens experienced by patients with kidney failure.
PMID: 40471680
ISSN: 2641-7650
CID: 5868172

Underrecognition of deceased donor kidney out-of-sequence allocation due to increasing use of free-text coding

Tucker, Emma G; Yu, Miko E; Adler, Joel T; Cron, David C; Sahni, Prateek V; Schold, Jesse D; Mohan, Sumit; Husain, Syed Ali
Out-of-sequence (OOS) allocation, the process by which organ procurement organizations (OPOs) can deviate from standard rank lists of potential recipients to expeditiously allocate deceased-donor kidneys, is increasing in the United States. We aimed to determine whether current OPO reporting practices obscure the extent of OOS allocation. Using match-run data for all US deceased-donor kidney transplants from 2021-2023, we defined miscoded OOS (mOOS) allocation transplants as those with use of the 799 or 898 OPO-initiated refusal codes (other, specify) with free-text responses clearly indicating OOS allocation and compared them with explicit OOS allocation, in which OOS transplants are appropriately coded using refusal codes 861 to 863. We found that the prevalence of mOOS allocation increased from 2021 (122 transplants) to 2023 (430 transplants) and accounted for 12% of all OOS transplants by 2023. Organs allocated via mOOS had a lower median kidney donor profile index than those allocated via explicit OOS (51% vs 55%, P < .01). While an increasing number of OPOs used mOOS throughout the study period, the practice remained concentrated overall, with 5 high-frequency OPOs performing 66% of mOOS allocations in 2023. These findings highlight the need for stricter oversight of organ allocation and underscore the responsibility of the Organ Procurement and Transplant Network to ensure proper data reporting.
PMID: 40209903
ISSN: 1600-6143
CID: 5868132

Nonstandard coding of deceased-donor kidney out-of-sequence allocation leads to underrecognition of allocation deviations

Tucker, Emma G; Yu, Miko E; Adler, Joel T; Cron, David C; Sahni, Prateek V; Schold, Jesse D; Mohan, Sumit; Husain, Syed Ali
Out-of-sequence (OOS) allocation, the process by which organ procurement organizations (OPOs) can deviate from standard rank lists of potential recipients to expeditiously allocate deceased-donor kidneys, is rising in the U.S. We aimed to determine whether current OPO reporting practices obscure the extent of OOS allocation. Using match-run data for all U.S. deceased-donor kidney transplants from 2021-2023, we defined "miscoded" OOS (mOOS) allocation transplants as those with use of the 799 or 898 OPO- initiated refusal codes ("other, specify") with free text responses clearly indicating OOS allocation, and compared these to "explicit" OOS (eOOS) allocation, wherein OOS transplants are appropriately coded using refusal codes 861-863. We found that the prevalence of mOOS allocation increased from 2021 (122 transplants) to 2023 (430 transplants) and accounted for 12% of all OOS transplants by 2023. Organs allocated via mOOS had a lower median KDPI than those allocated via eOOS (51% vs 55%, p <0.01). While an increasing number of OPOs used mOOS throughout the study period, the practice remained concentrated overall, with 5 "outlier" OPOs performing 66% of mOOS allocations in 2023. These findings highlight the need for stricter oversight of organ allocation and underscore the responsibility of the OPTN to ensure proper data reporting.
PMID: 40061353
CID: 5868122

Equity and the operational considerations of the kidney transplant allocation system

Mohan, Sumit; Yu, Miko; Husain, S Ali
PURPOSE OF REVIEW/OBJECTIVE:Demonstrate the impact of allocation system design on access to the waitlist and transplantation for patients with end-stage kidney disease (ESKD). RECENT FINDINGS/RESULTS:Minoritized groups are more likely to be declined from transplant listing owing to psychosocial criteria. Lack of consistent definitions, screening tools with differential subgroup validity, and insufficient evidence-base contribute to concerns about reliance on psychosocial factors in transplant listing decisions. SUMMARY/CONCLUSIONS:Although kidney transplantation is the preferred treatment choice, a shrinking proportion of prevalent patients are waitlisted for this option in the United States, even among our youngest ESKD patients. Recent HRSA proposals to expand data collection to encompass the prewaitlisting process suggest a timely need to capture additional data on transplant referrals to improve access to transplantation. In 2021, KAS250 was implemented in response to concerns of geographic inequities in transplant rates. However, updates to this system have also resulted in a dramatic rise in organ offers, the number of offers needed to successfully place an organ and lowered utilization rates. Since KAS250, the use of alternative pathways to improve organ utilization rates, such as out-of-sequence placements has increased dramatically across the organ quality spectrum and risk exacerbating disparities in access to transplant. Additionally, the current absence of meaningful oversight risks undermining the perception of the transplant system as an objective process. SUMMARY/CONCLUSIONS:There is a need for a more robust evaluation of recent iterative changes in waitlist and organ allocation practices to ensure equity in access for our most vulnerable patients.
PMCID:11962740
PMID: 39760137
ISSN: 1531-7013
CID: 5868092

Increasing Incidence of Out-of-Sequence Allocation of Deceased Donor Kidneys

Cron, David C; Husain, S Ali; Kuk, Arnold E; Mohan, Sumit; Adler, Joel T
PMCID:11793170
PMID: 39760230
ISSN: 2641-7650
CID: 5868102

Patient and Provider Attitudes Toward Patient-Facing Kidney Organ Offer Reporting

Husain, Syed Ali; Rubenstein, Jordan A; Ramsawak, Seshma; Huml, Anne M; Yu, Miko E; Maclay, Lindsey M; Schold, Jesse D; Mohan, Sumit
INTRODUCTION/UNASSIGNED:In the United States (US), deceased donor kidney offers are most commonly declined by transplant centers on behalf of waitlisted candidates, without notifying them. We sought to understand patient and provider attitudes toward patient-facing organ offer reporting. METHODS/UNASSIGNED:We conducted a cross-sectional survey of patients, nephrologists, and nephrology social workers on the National Kidney Foundation mailing list and the medical and surgical directors of US kidney transplant programs. RESULTS/UNASSIGNED:Among 755 patient respondents, 64% wanted to receive organ offer reports. Patients who wanted organ offer information were younger, more likely to be of a non-White race, and more likely to be on dialysis or on the waiting list. Of the patients, 87% reported that centers should be required to tell candidates about the offers they receive, and 62% reported that candidates should be informed after every offer. Among the 107 nephrology respondents, 73% reported that candidates should be provided with organ offer information and 88% reported that they would want to receive a copy of their patients' offer reports. Among 26 transplant program director respondents, 77% reported that candidates should not be notified of offers declined on their behalf. If organ offer reports were required, most program director respondents believed that they should include the reasons offers were declined and should not include offers for kidneys that were ultimately discarded. CONCLUSIONS/UNASSIGNED:Most patients and nephrology providers, but only a minority of transplant program directors, supported the sharing of patient-facing information about individual deceased donor kidney offers that were declined on candidates' behalf.
PMCID:12034868
PMID: 40303216
ISSN: 2468-0249
CID: 5868142